What you need to know about the latest FDA approval.
FDA approves apalutamide for castration-resistant prostate cancer.
Delafloxacin (Baxdela) for treatment of acute bacterial skin and skin structure infections including cellulitis, wound infection, major cutaneous abscess, and burn infection.
Abilify MyCite is the first drug to contain a bit of technology that reports that it has been taken as prescribed.
Edaravone has been approved for patients with amyotropic lateral sclerosis.
The FDA has approved ocrelizumab for treating relapsing forms of multiple sclerosis and primary progressive multiple sclerosis.
The FDA approved Kevzara for RA patients.
More information could help save lives.
New technology is helping patients, nurses, and pharmacists alike.
New product uses new technology to break down earwax